Real-time enrollment status for this cervical cancer clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 7:54 AM UTC
| NCT Number | NCT07216703 |
| Recruiting Status | Recruiting |
| Condition | Cervical Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,023 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 13, 2026 (Yesterday) |
As of October 14, 2026: Clinical trial NCT07216703 is currently recruiting participants. This phase3 study for cervical cancer is actively seeking new participants at 30 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216703 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216703 was last updated Yesterday (October 13, 2026). HelloStudys verifies this status automatically.